REJUVANAD+
LIVE

Serial Number

79425415

Owner

KIM, Young Woo

Attorney

Kisuk Lee

Filing Date

Apr 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

REJUVANAD+ Trademark

Serial Number: 79425415

REJUVANAD+ is a trademark filed by KIM, Young Woo on April 11, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

KIM, Young Woo (4 trademarks)

4-dong 1002-ho,

Entity Type: 98

Trademark Details

Filing Date

April 11, 2025

Registration Date

Not Registered

Published for Opposition

June 30, 2026

Goods & Services

Pharmaceutical preparations for the treatment of age-related cellular decline; pharmaceutical preparations for anti-aging purposes; pharmaceutical preparations for cognitive enhancement and mental clarity; pharmaceutical preparations for boosting energy levels and treating fatigue; pharmaceutical preparations for supporting DNA repair; pharmaceutical preparations for cellular rejuvenation and metabolic support; pharmaceutical preparations for physical recovery; Pharmaceutical compositions, namely, nicotinamide adenine dinucleotide (NAD+) preparations for medical use, namely, for the treatment of cellular aging; pharmaceutical compositions, namely, coenzyme preparations for medical use, namely, for the treatment of cellular aging; pharmaceutical compositions, namely, anti-aging pharmaceutical preparations for the treatment of cellular aging; Pharmaceutical drugs for the treatment of age-related cellular decline; pharmaceutical drugs for the treatment of fatigue; pharmaceutical drugs for the treatment of cognitive impairment; pharmaceutical drugs for the treatment of metabolic disorders; Cough pastilles for medical use; Medicinal infusions for treating fatigue and age-related conditions; Medicine preparations for human use for anti-aging purposes; medicine preparations for human use for cellular health support; medicine preparations for human use for the treatment of age-related conditions and fatigue; Non-prescription medicine preparations for general health and wellness support; non-prescription medicine preparations for anti-aging support; non-prescription medicine preparations for energy and vitality support; Pre-filled syringes containing nicotinamide adenine dinucleotide (NAD+) for medical purposes; prefilled syringes containing pharmaceutical preparations for anti-aging and cellular rejuvenation, for medical purposes; Pharmaceutical preparations for antiaging skin care; Anti-aging pharmaceutical compositions for skin care; Pharmaceutical preparations for skin care; Medicated skin care preparations for medical purposes; Medicated skin care preparations; Injectable dermal fillers for medical purposes; Medicated creams for skin care and protection of the skin; all the foregoing containing nicotinamide adenine dinucleotide

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Jun 25, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 10, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 10, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
May 22, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2026 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 27, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 27, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 27, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 27, 2026 COAR
REFUSAL PROCESSED BY IB
Nov 15, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 27, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 27, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 9, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 8, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 6, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 5, 2025 REPR